<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wikidot="http://www.wikidot.com/rss-namespace">

	<channel>
		<title>Brast Cancer Case #1 (ported from radonc.wikidot</title>
		<link>http://isocentre.wikidot.com/forum/t-257646/brast-cancer-case-1-ported-from-radonc-wikidot</link>
		<description>Posts in the discussion thread &quot;Brast Cancer Case #1 (ported from radonc.wikidot&quot; - Psot-mastectomy recurrence after all therapies initially</description>
				<copyright></copyright>
		<lastBuildDate>Fri, 04 Sep 2026 15:00:44 +0000</lastBuildDate>
		
					<item>
				<guid>http://isocentre.wikidot.com/forum/t-257646#post-846286</guid>
				<title>Re: Brast Cancer Case #1 (ported from radonc.wikidot</title>
				<link>http://isocentre.wikidot.com/forum/t-257646/brast-cancer-case-1-ported-from-radonc-wikidot#post-846286</link>
				<description></description>
				<pubDate>Mon, 09 Aug 2010 13:42:58 +0000</pubDate>
				<wikidot:authorName>Santam Chakraborty </wikidot:authorName>				<wikidot:authorUserId>416676</wikidot:authorUserId>				<content:encoded>
					<![CDATA[
						 <p>Hi,<br /> Dr Sharma our HOD, has got a good experience with HDR surface moulds in this setting. We generally give a dose of 3&#160;Gy to a total dose of 36 - 42&#160;Gy by HDR treating twice a day. However he treats patients where the longest dimension of the mould will not exceed &gt; 5 -6&#160;cm (area ~ 30 -40 cm2.) I have seen personally 3 -4 patients with chest wall recurrence on F/U post surface mould treatment with follow-up of 3 - 4 years without significant local complications other than local telengiectasia. However as is the natural history these patients usually will fail systemically over 1 -2 years time usually. However the rules he follows for the mould are the rules of the manchester system. I personally will be more comfy with a CT based plan with optimization (hyperdose sleeves are less of consequence here - what is important is the dose homogenity in the surface with rapid dose fall -off. That said I see no reason why this excellent method of local treatment should not be offered.<br /> P.S. Surface mould may give a less conformal result in terms of underlying lung dose as compared to electron if you keep the height of the mould too high to homogenize the target dose.</p> 
				 	]]>
				</content:encoded>							</item>
					<item>
				<guid>http://isocentre.wikidot.com/forum/t-257646#post-845818</guid>
				<title>Re: Brast Cancer Case #1 (ported from radonc.wikidot</title>
				<link>http://isocentre.wikidot.com/forum/t-257646/brast-cancer-case-1-ported-from-radonc-wikidot#post-845818</link>
				<description></description>
				<pubDate>Sun, 08 Aug 2010 18:32:24 +0000</pubDate>
				<wikidot:authorName>Nikhilesh Patil</wikidot:authorName>				<wikidot:authorUserId>416151</wikidot:authorUserId>				<content:encoded>
					<![CDATA[
						 <p>Brachy can be done, the advantage is obvious dose fall off. However one needs to remind himself of PARIS system rules (year 1921) and not end up having big hyper dose sleeve's around the sources. I don't know exactly what are her chances of having necrosis/ rib fracture etc.,</p> <p>I have a case coming up, recurrent ca-breast , Chest wall recurrence along with systemic disease. Our tumor board has asked us if we can do something for her, may be palliative surface mould for our patient. Havn't seen the patient yet.</p> <p>Nikhilesh</p> 
				 	]]>
				</content:encoded>							</item>
					<item>
				<guid>http://isocentre.wikidot.com/forum/t-257646#post-845805</guid>
				<title>Re: Brast Cancer Case #1 (ported from radonc.wikidot</title>
				<link>http://isocentre.wikidot.com/forum/t-257646/brast-cancer-case-1-ported-from-radonc-wikidot#post-845805</link>
				<description></description>
				<pubDate>Sun, 08 Aug 2010 18:11:35 +0000</pubDate>
				<wikidot:authorName>Rohit Malde</wikidot:authorName>				<wikidot:authorUserId>418807</wikidot:authorUserId>				<content:encoded>
					<![CDATA[
						 <p>Literature review suggests surface mould has been tried and appears feasible with minimal complications, but its efficacy remains controversial with case series and reports.</p> <p>However there is no long term follow up nor any metion of late radiation sequaela. There is more experience of re-irradiation by external beam but that is essentially is a palliative setting with mean doses of 20 to 30&#160;Gy.</p> <p>In a more radical scenario,the largest series i could find in the <strong><span style="text-decoration: underline;">post mastectomy irradiated chest wall setting</span></strong> was:</p> <p>1. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17869019">http://www.ncbi.nlm.nih.gov/pubmed/17869019</a></p> <p>The median follow-up from the second RT course was too short (just 1 year) Four patients developed late Grade 3 or 4 toxicity out of 81. However, 25 patients had follow-up &gt;20 months, and no late Grade 3 or 4 toxicities were noted. Interesting,but its difficult to get the actual incidence of late damage from this publication.</p> <p>The incidence of late damage will of course be proportional to the dose of radiotherapy making its use beyond 50&#160;Gy probably unfeasible for a normally cautious oncologist, even if a localised volume to the chest wall is re-irradiated. But to be very honest for Andrew it could be SKY IS the LIMIT. What have you got to lose &#8230; rib fractures, soft tissue necrosis &#8230;. are these really serious to give you nightmares</p> <p>And its upto a radiation oncologist to believe in his magic treatment, whether would 50&#160;Gy do the job and give this lady a 50% or 80% chance of being free from local relapse. I m sure nobody other than Andrew himself will understand this equation of higher the dose, higher the chance of local control but equally distressing would be the chance of soft tisse necrosis and late damage.</p> <p>I have to see Andrew sitting with this patient, going through a graph and telling the patient, look lady what do you want.<br /> You want 40&#160;% chance of local control with 30&#160;% chance of late damage<br /> or 60% chance of local control with 50% chance of late damage<br /> or a 80% chance of local control with 70% chance of late damage.<br /> Common lady, its your choice at the end of the day.</p> <p>Sorry, Andrew just pulling your leg, those figures are just arbitrary and not real, so others please dont take these for granted since they are just from me.</p> <p>This earlier publication , <a href="http://www.ncbi.nlm.nih.gov/pubmed/9342443?dopt=Abstract">http://www.ncbi.nlm.nih.gov/pubmed/9342443?dopt=Abstract</a></p> <p>makes me believe that evetually this patient would have a systemic relapse if she is fortunate to have had a good local control.<br /> But we are always optimistic, hence 10 y OS = 30% is the best realistic estimate you could have for this patient with isolated local relapse.</p> <p>Such a fuss about this positive margin , microscopic disease which we cant even see, but can be a matter of life or death for this 52 y old lady.</p> 
				 	]]>
				</content:encoded>							</item>
					<item>
				<guid>http://isocentre.wikidot.com/forum/t-257646#post-845777</guid>
				<title>Re: Brast Cancer Case #1 (ported from radonc.wikidot</title>
				<link>http://isocentre.wikidot.com/forum/t-257646/brast-cancer-case-1-ported-from-radonc-wikidot#post-845777</link>
				<description></description>
				<pubDate>Sun, 08 Aug 2010 17:20:56 +0000</pubDate>
				<wikidot:authorName>adjuvant</wikidot:authorName>				<wikidot:authorUserId>534532</wikidot:authorUserId>				<content:encoded>
					<![CDATA[
						 <p>Any role for brachy??<br /> What is the chance of necrosis?<br /> What is the chance of cure? Can we apply that 5 and 10 year survival as the answer to this question?</p> 
				 	]]>
				</content:encoded>							</item>
					<item>
				<guid>http://isocentre.wikidot.com/forum/t-257646#post-845742</guid>
				<title>Re: Brast Cancer Case #1 (ported from radonc.wikidot</title>
				<link>http://isocentre.wikidot.com/forum/t-257646/brast-cancer-case-1-ported-from-radonc-wikidot#post-845742</link>
				<description></description>
				<pubDate>Sun, 08 Aug 2010 16:16:01 +0000</pubDate>
				<wikidot:authorName>Nikhilesh Patil</wikidot:authorName>				<wikidot:authorUserId>416151</wikidot:authorUserId>				<content:encoded>
					<![CDATA[
						 <p>I agree with Rohit, will check with Thoracic surgeons if they can resect if not then RT in some form. Electron arc can be offered. If the target is thin then surface mould is another option.<br /> Patient needs to understand well, there is a risk to doing all this.<br /> Nikhilesh</p> 
				 	]]>
				</content:encoded>							</item>
					<item>
				<guid>http://isocentre.wikidot.com/forum/t-257646#post-845678</guid>
				<title>Re: Brast Cancer Case #1 (ported from radonc.wikidot</title>
				<link>http://isocentre.wikidot.com/forum/t-257646/brast-cancer-case-1-ported-from-radonc-wikidot#post-845678</link>
				<description></description>
				<pubDate>Sun, 08 Aug 2010 14:00:33 +0000</pubDate>
				<wikidot:authorName>Rohit Malde</wikidot:authorName>				<wikidot:authorUserId>418807</wikidot:authorUserId>				<content:encoded>
					<![CDATA[
						 <p>Options:</p> <p>1. <span style="text-decoration: underline;"><strong>My preferred Option</strong></span>: Discuss this with Plastic Oncosurgeon or Thoracic Surgeon for further curative resection as this lady is too young (52 yrs).<br /> Let the surgeoon know that median survival forthese patients is 5.6 years and 10 y OS = 30% which is reasonable.<br /> <a href="http://www.ncbi.nlm.nih.gov/pubmed/9342443?dopt=Abstract">http://www.ncbi.nlm.nih.gov/pubmed/9342443?dopt=Abstract</a></p> <p>2. <span style="text-decoration: underline;"><strong>Re-irradiation</strong></span>: The equation between Cure Vs Complication would tilt more towards the latter.<br /> i personally dont think you could safely achieve this.<br /> You need at least 60&#160;Gy minimum for this microscopic disease.<br /> You could use electrons (with bolus) or kV.<br /> Its highly likely this treatment may result in soft tissue necrosis and/or osteoradionecrosis of ribs which could be as high as 40-60%.</p> <p>And of course you could ask your plastic Surgeon or Thoracic Surgeon to get you out of that mess in may be 2011 or 2012 with some chest wall reconstruction procedure.</p> <p>3. Observe</p> <p>(Many times we ve seen, patients have positive margin, however on further resection there is no e/o residual cancer.</p> <p>I would re-check her ER, PR and Her-2 receptor status on the current resection and consider any systemic therapy along those lines if necessary.</p> 
				 	]]>
				</content:encoded>							</item>
					<item>
				<guid>http://isocentre.wikidot.com/forum/t-257646#post-845451</guid>
				<title>Brast Cancer Case #1 (ported from radonc.wikidot</title>
				<link>http://isocentre.wikidot.com/forum/t-257646/brast-cancer-case-1-ported-from-radonc-wikidot#post-845451</link>
				<description></description>
				<pubDate>Sun, 08 Aug 2010 02:32:18 +0000</pubDate>
				<wikidot:authorName>AAM</wikidot:authorName>				<wikidot:authorUserId>61952</wikidot:authorUserId>				<content:encoded>
					<![CDATA[
						 <p>52 Female. Diagnosed with T4 N1 M0 @ presentation 4 years ago. Treated with Neoadj Chemo + MRM + Adj XRT to chest wall and axilla/scn</p> <p>Now presents with local chest wall mass. We saw her post resection of the mass by surgeon. + deep margin . Surgeon believes can not remove it by resection.</p> <p>Re-staging—&gt; No Metastasis.</p> <ol> <li>What would be your treatment options?</li> <li>If RT? How to deliver to give least chance of XRT necrosis?</li> <li>What is the chance of soft tissue XRT induced necrosis?</li> <li>If happens what would be the treatment options?</li> </ol> 
				 	]]>
				</content:encoded>							</item>
				</channel>
</rss>